Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Plc Regulatory News (ZTF)

Share Price Information for Zotefoams Plc (ZTF)

Share Price is delayed by 15 minutes
Get Live Data
433.00    3.00 (0.70%)
Bid:
431.00
Ask:
433.50
Spread: 2.50 (0.58%)
Market Cap: £212.96m
ZTF Live PriceLast checked at - London Stock Exchange

Intraday Zotefoams Plc Share Chart

Trading Update

3 Oct 2019 07:00

RNS Number : 5917O
Zotefoams PLC
03 October 2019
 

Zotefoams plc

 

("Zotefoams" or "the Group")

 

Trading Update

 

 

3 October 2019. Zotefoams, a world leader in cellular materials technology, today provides an update on trading.

At the time of our interim results in August we stated that we were mindful of a difficult current trading environment in the European polyolefin foams markets and the less stable political and macroeconomic environment. Since that time the market for polyolefin foams in continental Europe has deteriorated significantly while growth in the North American market has slowed and is now expected to be below our previous estimates.

We anticipate polyolefin foam sales are therefore likely to be around £6 million below current market estimates, resulting in Group sales for the second half of 2019 approximately £2m below the first half of the year. Anticipated profit for this period is impacted by our limited ability to change the operational gearing in the business in this timeframe.

Our High-Performance Products ("HPP") business unit is performing as expected with strong growth in T-FIT® insulation products and ZOTEK® technical foams mainly in aviation and footwear.

Notwithstanding the near-term headwinds in the polyolefin foams business, the Board remains confident in the growth strategy and capacity enhancement investments the Company is making and in the long-term prospects of the business.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation ("MAR") EU no.596/2014. Upon the publication of this announcement via Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

 

Enquiries:

Zotefoams plc

+44 (0) 208 664 1600

David Stirling, Group CEO

 

Gary McGrath, Group CFO

 

 

 

IFC Advisory (Financial PR & IR)

+44 (0) 203 934 6630

Graham Herring

Zach Cohen

 

 

 

 

About Zotefoams plc

 

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® polyolefin and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. In addition, Zotefoams owns and licenses patented MuCell® microcellular foam technology, developed specifically for extrusion applications, from a base in Massachusetts, USA to customers worldwide.

 

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky and Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT®). A third foam-manufacturing site, in Poland, is planned to begin operations in 2020.

 

www.zotefoams.com

 

AZOTE®, ZOTEK®, T-FIT® are registered trademarks of Zotefoams plc

MuCell® is a registered trademark of Trexel Inc.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUGGGWUUPBPGP
Date   Source Headline
22nd Apr 20257:00 amRNS2024 Annual Report & Notice of 2025 AGM
15th Apr 20257:00 amRNSIssue of Equity
11th Apr 20254:14 pmRNSNotification Of Transactions Of Directors/PDMRs
9th Apr 20253:25 pmRNSHolding(s) in Company
2nd Apr 20254:37 pmRNSDirector Declaration
20th Mar 20253:16 pmRNSHolding(s) in Company
19th Mar 20251:52 pmRNSHolding(s) in Company
18th Mar 20257:00 amRNSPreliminary Results
17th Mar 20251:00 pmRNSResults Presentation on Investor Meet Company
12th Mar 20252:50 pmRNSNotification Of Transactions Of Directors/PDMRs
10th Mar 20257:00 amRNSStrategic Investment in Asia
4th Mar 20254:41 pmRNSHolding(s) in Company
3rd Mar 20257:00 amRNSCFO Retirement
27th Feb 20253:58 pmRNSHolding(s) in Company
12th Feb 20251:35 pmRNSNotification Of Transactions Of Directors/PDMRs
27th Jan 202511:34 amRNSHolding(s) in Company
23rd Jan 20257:00 amRNSTrading Update & Notice of Capital Markets Day
15th Jan 202511:04 amRNSNotification Of Transactions Of Directors/PDMRs
24th Dec 20247:00 amRNSNotification Of Transactions Of Directors/PDMRs
18th Dec 20247:00 amRNSUpdate on ReZorce
13th Dec 20243:41 pmRNSHolding(s) in Company
12th Dec 20249:47 amRNSNotification Of Transactions Of Directors/PDMRs
26th Nov 20244:21 pmRNSHolding(s) in Company
25th Nov 20245:51 pmRNSHolding(s) in Company
12th Nov 20242:27 pmRNSNotification Of Transactions Of Directors/PDMRs
4th Nov 20247:00 amRNSTrading Update
14th Oct 202410:02 amRNSNotification Of Transactions Of Directors/PDMRs
8th Oct 20242:17 pmRNSNotification Of Transactions Of Directors/PDMRs
12th Sep 20241:20 pmRNSNotification Of Transactions Of Directors/PDMRs
23rd Aug 202411:42 amRNSHolding(s) in Company
14th Aug 20247:00 amRNSNotification Of Transactions Of Directors/PDMRs
6th Aug 20247:00 amRNSInterim Results
12th Jul 20244:14 pmRNSNotification Of Transactions Of Directors/PDMRs
8th Jul 20247:00 amRNSNotice of Results and Investor Presentation
5th Jul 20241:14 pmRNSHolding(s) in Company
13th Jun 20247:00 amRNSNotification Of Transactions Of Directors/PDMRs
5th Jun 20243:08 pmRNSNotification Of Transactions Of Directors/PDMRs
31st May 20244:45 pmRNSHolding(s) in Company
30th May 20243:07 pmRNSDirector/PDMR Shareholding
28th May 20247:00 amRNSNotification Of Transactions Of Directors/PDMRs
22nd May 20242:01 pmRNSResult of the 2024 Annual General Meeting
22nd May 20247:00 amRNSTrading Update and Group CEO Succession
15th May 202410:07 amRNSNotification Of Transactions Of Directors/PDMRs
15th May 20247:00 amRNSUpdate on ReZorce® & beverage carton Media Launch
10th May 20247:01 amRNSNotification Of Transactions Of Directors/PDMRs
10th May 20247:00 amRNSNotification Of Transactions Of Directors/PDMRs
7th May 20247:00 amRNSZotefoams and Shincell Global Alliance
19th Apr 20247:00 amRNSExclusivity agreement with Design Blue Limited
19th Apr 20247:00 amRNS2023 Annual Report & Notice of 2024 AGM
12th Apr 20244:34 pmRNSNotification Of Transactions Of Directors/PDMRs

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.